Boston, MA 的 出血 臨床試驗
10 項針對 出血 的研究正在 Boston(約 30 英里範圍內)及其周邊地點尋找參與者。開啟研究以查看參與資格及聯絡研究團隊的方式。
官方研究文本(英文)
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Safety in Adult Participants With Atrial Fibrillation Who Are Treated With Anticoagulation
招募中2 期
- Beth Israel Lahey Health, Beth Israel Deaconess Medical Center (BIDMC), Boston
Delivering tAN to Reduce HMB: The LUNA Study
招募中
- Lindus Health - DECENTRALIZED STUDY, Boston
Comparing the Safety and Efficacy of Apixaban and Rivaroxaban
招募中4 期
- Boston VA CSP Coordinating Center, Boston
- VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Onyx™ Liquid Embolic IDE Clinical Study
招募中
- Masschusetts General Hospital, Boston
A Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Massachusetts General Hospital, Boston
A Follow-up Study of Mezagitamab in Adults With Chronic Primary Immune Thrombocytopenia
招募中3 期
- Massachusetts General Hospital, Boston
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
招募中3 期
- Massachusetts General Hospital, Boston
- Brigham and Women's Hospital, Boston
Safety, Feasibility, and Efficacy of Non-invasive Vagus Nerve Stimulation (nVNS) in the Treatment of Aneurysmal Subarachnoid Hemorrhage
招募中
- Massachusetts General Hospital, Boston
NIRS Monitoring in Premature Infants
招募中觀察性研究歡迎健康志工
- Boston Children's Hospital, Boston
The Neonatal Hemorrhagic Risk Assessment in Thrombocytopenia
招募中觀察性研究
- Boston Children's Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
其他城市的 出血 試驗
- New York City, NY8 項研究
- Houston, TX7 項研究
- Atlanta, GA6 項研究
- Cleveland, OH6 項研究
- Chicago, IL6 項研究
- St. Louis, MO5 項研究
- Durham, NC5 項研究
- Philadelphia, PA5 項研究
- Seattle, WA5 項研究
- Mountain View, CA4 項研究
- Washington, DC4 項研究
- Indianapolis, IN4 項研究
Boston 的其他研究
- 乳癌111 項研究
- 非小細胞肺癌89 項研究
- 癌症(所有類型)86 項研究
- 大腸直腸癌63 項研究
- 轉移性癌症63 項研究
- 肺癌62 項研究
- 卵巢癌61 項研究
- 前列腺癌60 項研究
- 憂鬱症52 項研究
- 子宮內膜癌50 項研究
- 急性髓系白血病44 項研究
- 胰臟癌44 項研究
資料來源:ClinicalTrials.gov,擷取日期 2026年10月2日。各研究自行設定資格標準;由研究團隊決定參與者資格。